Annual Cash & Cash Equivalents
$7.27 M
-$920.10 K-11.24%
31 December 2023
Summary:
Monopar Therapeutics annual cash & cash equivalents is currently $7.27 million, with the most recent change of -$920.10 thousand (-11.24%) on 31 December 2023. During the last 3 years, it has fallen by -$9.47 million (-56.59%). MNPR annual cash & cash equivalents is now -64.21% below its all-time high of $20.30 million, reached on 31 December 2021.MNPR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.02 M
-$99.80 K-1.63%
30 September 2024
Summary:
Monopar Therapeutics quarterly cash and cash equivalents is currently $6.02 million, with the most recent change of -$99.80 thousand (-1.63%) on 30 September 2024. Over the past year, it has increased by +$504.70 thousand (+9.15%). MNPR quarterly cash and cash equivalents is now -76.60% below its all-time high of $25.72 million, reached on 31 March 2021.MNPR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | +9.2% |
| 3 y3 years | -56.6% | -73.0% |
| 5 y5 years | +5.4% | +33.9% |
MNPR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.2% | at low | -73.0% | +9.2% |
| 5 y | 5 years | -64.2% | +5.4% | -76.6% | +33.9% |
| alltime | all time | -64.2% | +250.6% | -76.6% | +33.9% |
Monopar Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.02 M(-1.6%) |
| June 2024 | - | $6.12 M(-21.6%) |
| Mar 2024 | - | $7.81 M(+7.5%) |
| Dec 2023 | $7.27 M(-11.2%) | $7.27 M(+31.7%) |
| Sept 2023 | - | $5.52 M(-23.6%) |
| June 2023 | - | $7.21 M(+26.0%) |
| Mar 2023 | - | $5.73 M(-30.1%) |
| Dec 2022 | $8.19 M(-59.7%) | $8.19 M(-42.8%) |
| Sept 2022 | - | $14.32 M(-13.0%) |
| June 2022 | - | $16.46 M(-7.6%) |
| Mar 2022 | - | $17.82 M(-12.2%) |
| Dec 2021 | $20.30 M | $20.30 M(-9.1%) |
| Sept 2021 | - | $22.34 M(-8.0%) |
| June 2021 | - | $24.29 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $25.72 M(+53.7%) |
| Dec 2020 | $16.74 M(+26.7%) | $16.74 M(-6.9%) |
| Sept 2020 | - | $17.98 M(+43.3%) |
| June 2020 | - | $12.55 M(-0.4%) |
| Mar 2020 | - | $12.59 M(-4.7%) |
| Dec 2019 | $13.21 M(+91.7%) | $13.21 M(+194.0%) |
| Sept 2019 | - | $4.49 M(-12.4%) |
| June 2019 | - | $5.13 M(-12.8%) |
| Mar 2019 | - | $5.88 M(-14.7%) |
| Dec 2018 | $6.89 M(-23.3%) | $6.89 M(-9.5%) |
| Sept 2018 | - | $7.62 M(+2.7%) |
| June 2018 | - | $7.42 M(-9.2%) |
| Mar 2018 | - | $8.17 M(-9.0%) |
| Dec 2017 | $8.98 M(+333.4%) | $8.98 M |
| Dec 2016 | $2.07 M | - |
FAQ
- What is Monopar Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Monopar Therapeutics?
- What is Monopar Therapeutics annual cash & cash equivalents year-on-year change?
- What is Monopar Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Monopar Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MNPR is $7.27 M
What is the all time high annual cash & cash equivalents for Monopar Therapeutics?
Monopar Therapeutics all-time high annual cash & cash equivalents is $20.30 M
What is Monopar Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MNPR annual cash & cash equivalents has changed by -$920.10 K (-11.24%)
What is Monopar Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MNPR is $6.02 M
What is the all time high quarterly cash and cash equivalents for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly cash and cash equivalents is $25.72 M
What is Monopar Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MNPR quarterly cash and cash equivalents has changed by +$504.70 K (+9.15%)